Eli Lilly and Company (SWX:LLY)
Market Cap | 563.68B |
Revenue (ttm) | 43.32B |
Net Income (ttm) | 9.82B |
Shares Out | n/a |
EPS (ttm) | 10.86 |
PE Ratio | 57.42 |
Forward PE | 30.49 |
Dividend | 4.89 (0.78%) |
Ex-Dividend Date | May 16, 2025 |
Volume | n/a |
Average Volume | 3 |
Open | n/a |
Previous Close | 615.00 |
Day's Range | n/a |
52-Week Range | 540.00 - 833.88 |
Beta | 0.33 |
RSI | 52.08 |
Earnings Date | Aug 7, 2025 |
About Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Ja... [Read more]
Financial Performance
In 2024, Eli Lilly and Company's revenue was $45.04 billion, an increase of 32.00% compared to the previous year's $34.12 billion. Earnings were $10.59 billion, an increase of 102.08%.
Financial numbers in USD Financial StatementsNews
Eli Lilly: If You Don't Buy On Weight Loss Promise Now, You Probably Never Will
Lilly's Jake Van Naarden: Lilly's success with GLP-1's allows us to reinvest in oncology
CNBC's Angelica Peebles sits down with Lilly's Head of Oncology, Jake Van Naarden, to discuss what's next in Lilly's oncology pipeline and what Lilly is changing about its clinical trials to make them...

Should You Invest $1,000 in Eli Lilly today?

Welldoc Works with Lilly to Launch a New Personalized Health & Medicine Platform for Those Prescribed Lilly's Incretin Therapies
COLUMBIA, Md.--(BUSINESS WIRE)--Welldoc®, a leader in AI-powered digital health innovation, today announced it will power the newly launched Lilly Health™ Personalized Health & Medicine Platform* (Lil...

Prediction: Eli Lilly Will Reach a $1 Trillion Valuation by 2027
TGA approves weight-loss drug to treat sleep disorder
The medicines regulator has approved Eli Lilly’s Mounjaro weight-loss drug to be used to treat sleep apnoea.

Here's what is driving Tuesday's stock rally plus, an analyst comes to Eli Lilly's defense
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Eli Lilly, Camurus in major deal to develop obesity, diabetes drugs

Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
Partnership focused on development of long-acting therapies based on Camurus' FluidCrystal® technology and Eli Lilly's proprietary drug compounds Camurus eligible to receive up to $870 million in pote...

Top 50 High-Quality Dividend Stocks For June 2025
I track 50 high-quality dividend growth stocks to identify opportune investments, updating valuation ratings daily to focus on attractive opportunities. In this turbulent year, my investable universe ...

LLY Stock Too Cheap At $750?
Question: Why would you pay 81 times earnings for AbbVie stock when you can buy LLY for a similar valuation of 76 times earnings? You wouldn't, especially when you consider three simple facts:
Biotech Bull Case, ABVX International Interest, JNJ & LLY Options Trades
"You cannot not believe in science," says Tsvetta Kaleynska. She sees biotech companies outperforming in 2025 despite a slow start to the year.

Tech sector tumbles: Healthcare stocks shine amid market volatility
📈 Sector Overview Today's stock market heatmap reveals a dynamic yet volatile landscape, with technology stocks experiencing notable declines while the healthcare sector exhibits significant resilien...

Lilly to participate in Goldman Sachs 46th Annual Global Health Care Conference
INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) will participate in the Goldman Sachs 46th Annual Global Health Care Conference on June 10, 2025. Lucas Montarce, Lilly exe...
Targeting The NaV1.8 Pathway In Pain Management: Eli Lilly And Vertex Lead The Way

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting
INDIANAPOLIS , June 2, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new Phase 1 data showing that its folate receptor alpha (FRα) antibody-drug conjugate (ADC) (LY4170156) de...

Eli Lilly Rises 1.5% After Key Trading Signal
TradePulse Alert Confirms Early Up Move in LLY Eli Lilly (LLY) today experienced a Power Inflow, a significant event for those who follow where smart money goes and value order flow analytics in their...

Eli Lilly Rises 1.5% After Key Trading Signal
TradePulse Alert Confirms Early Up Move in LLY

Could Viking Therapeutics Become the Next Eli Lilly?
Notable healthcare headlines for the week: AstraZeneca, Eli Lilly, Bristol Myers in focus
Key deals this week: EOG Resources, VivoPower, Servotronics, Eli Lilly and more

Tech stocks struggle while healthcare gains: Today's market overview
Tech stocks struggle while healthcare gains: Today's market overview The US stock market is showcasing a dynamic landscape today, characterized by struggles within the semiconductor sector and encoura...

5 Alpha Generating Monsters
Any stock can generate alpha, but doing it consistently is rare. These 5 stocks have delivered alpha for 4 out of the last 5 years. Valuation is important, so I screen for it and eliminate overpriced ...

Lilly announces details of presentations at American Diabetes Association's (ADA) 85th Scientific Sessions
INDIANAPOLIS , May 29, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatr...
Novo Nordisk Is Shedding Muscle In The Weight-Loss Brawl With Eli Lilly
Novo Nordisk is rapidly ceding market share to Eli Lilly. And the paradigm shift is showing up in Novo Nordisk stock.